Does general anaesthesia with xenon gas improve protection of the brain when compared to general anaesthesia with a standard anaesthetic agent?
Comparison of the effects of xenon and sevoflurane anaesthesia on neurofilament light and tau protein in patients undergoing lithotripsy: a randomised trial
St. Vincent's Hospital Melbourne
18 participants
Mar 2, 2019
Interventional
Conditions
Summary
In this research project we will be comparing anaesthesia with xenon to anaesthesia with our usual anaesthetic agent, sevoflurane. Xenon has been used as an anaesthetic agent for many years but it’s use is limited because it is so expensive. In order to justify its use there needs to be good evidence that it has a significant benefit. One area in which xenon appears to have benefit is in protecting the brain during anaesthesia and surgery. There is growing evidence that having an anaesthetic and surgery can cause some problems with how the brain functions. This is of particular concern in infants and older people. This study is considering if there is evidence that xenon may be more protective of the brain than the usual anaesthetic. For the study, patients having a minor surgical procedure will have anaesthetic with either xenon or sevoflurane. We will take blood tests from both sets of patients. The blood tests will look for evidence of any harm to the brain cells of the patients to identify if one anaesthetic is better than the other.
Eligibility
Inclusion Criteria2
- Patients' undergoing lithotripsy at St. Vincent's Hospital, Melbourne.
- Patients' living within 30minutes travel time of St. Vincent's Hospital.
Exclusion Criteria5
- High risk of PONV (Apfel score 3 or greater)
- Severe respiratory disease (unable to tolerate inspired oxygen fraction less than 35%)
- Contraindication to airway management with laryngeal mask airway
- Contraindication to anaesthesia with a volatile agent
- Pre-existing neurodegenerative condition
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
General anaesthesia with xenon gas. Xenon gas will be used as the sole hypnotic agent to provide general anaesthesia for participants undergoing lithotripsy. It will be administered by the inhalational route at an inspired fraction of 60% for the duration of the anaesthetic (about 45minutes) by the anaesthetist. It's use will be in conjunction with an opiod infusion (remifentanil) and other standard anaesthetic care.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12618000916246